163rd ENMC International Workshop: Nucleoid and nucleotide biology in syndromes of mitochondrial DNA depletion myopathy 12-14 December 2008, Naarden, The Netherlands

Neuromuscular Disorders

Volumn 19, Issue 6, 2009, Pages 439-443

  Poulton, Joanna ^a   Holt, Ian J ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; DEOXYGUANOSINE; DIHYDROOROTATE DEHYDROGENASE INHIBITOR; DNA DIRECTED DNA POLYMERASE GAMMA; HELICASE; LEFLUNOMIDE; MITOCHONDRIAL DNA; NUCLEOTIDE; PYRIMIDINE; RIBONUCLEOTIDE REDUCTASE; SUCCINYL COENZYME A; THYMIDINE KINASE; THYMIDINE PHOSPHORYLASE;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; DIALYSIS; DIET RESTRICTION; DIET SUPPLEMENTATION; DNA DETERMINATION; DRUG RESEARCH; ENZYME REPLACEMENT; GENE DELETION; HUMAN; MITOCHONDRIAL DNA DEPLETION SYNDROME; MITOCHONDRIAL DNA REPLICATION; MOLECULAR BIOLOGY; NETHERLANDS; NUCLEOTIDE METABOLISM; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; WORKSHOP;

DEOXYGUANOSINE; DNA HELICASES; DNA, MITOCHONDRIAL; DNA-DIRECTED DNA POLYMERASE; HUMANS; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MITOCHONDRIAL MYOPATHIES; MUTATION; NUCLEOTIDES;

EID: 67349211753     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2009.04.009     Document Type: Article

References (48)

1. Moraes C.T., Shanske S., Tritschler H.J., Aprille J.R., Andreetta F., Bonilla E., et al. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 48 (1991) 492-501
2. Moraes C., Ricci E., Arnaudo E., Bonilla E., DiMauro S., and Schon E. Quantitative defects of mitochondrial DNA. In: DiMauro S., and Wallace D. (Eds). Mitochondrial DNA in human pathology (1993), Raven, New York 97-108
3. Ashley N., Adams S., Slama A., Zeviani M., Suomalainen A., Andreu A., et al. Defects in maintenance of mitochondrial DNA are associated with intramitochondrial nucleotide imbalances. Hum Mol Genet 16 (2007) 1400-1411
4. Rötig A, Poulton J. Genetic causes of mitochondrial DNA depletion in humans Biochim Biophys Acta Mol Basis Dis (ELS), in press.
5. Alberio S., Mineri R., Tiranti V., and Zeviani M. Depletion of mtDNA: syndromes and genes. Mitochondrion 7 1-2 (2007) 6-12
6. Sarzi E., Bourdon A., Chretien D., Zarhrate M., Corcos J., Slama A., et al. Mitochondrial DNA depletion is a prevalent cause of multiple respiratory chain deficiency in childhood. J Pediatr 150 5 (2007) 531-534 4 e1-6
7. Rahman S., and Poulton J. Diagnosis of mitochondrial DNA depletion syndromes. Arch Dis Child 94 1 (2009) 3-5
8. Chinnery PF, Zeviani M. 155th ENMC workshop: Polymerase gamma and disorders of mitochondrial DNA synthesis, 21-23 September 2007, Naarden, The Netherlands. Neuromuscul Disord 2007.
9. Barthelemy C., de Baulny H.O., and Lombes A. D-loop mutations in mitochondrial DNA: link with mitochondrial DNA depletion?. Hum Genet 110 5 (2002) 479-487
10. Naviaux RK. Alpers syndrome. Orphanet: the portal for rare diseases and orphan drugs 2006. Available from: http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=1730&Disease_Disease_Search_diseaseGroup=alpers&Disease_Disease_Search_diseaseType=Pat&Disease(s)%20concerned=Alpers-syndrome&title=Alpers-syndrome&search=Disease_Search_Simple.
11. Poulton J., Sewry C., Potter C., Bourgeron T., Chretien D., Wijburg F., et al. Variation in mitochondrial DNA levels in muscle from normal controls. Is depletion of mitochondrial DNA in patients with mitochondrial myopathy a distinct clinical syndrome?. J Inherit Metab Dis 18 (1995) 4-20
12. Yasukawa T., Reyes A., Cluett T.J., Yang M.Y., Bowmaker M., Jacobs H.T., et al. Replication of vertebrate mitochondrial DNA entails transient ribonucleotide incorporation throughout the lagging strand. EMBO J 25 22 (2006) 5358-5371
13. Chen J., Kadlubar F.F., and Chen J.Z. DNA supercoiling suppresses real-time PCR: a new approach to the quantification of mitochondrial DNA damage and repair. Nucleic Acids Res 35 4 (2007) 1377-1388
14. Human DNA polymerase gamma mutation database [database on the Internet]. NIEHS 2009. Available from: http://tools.niehs.nih.gov/polg/.
15. Ferraro P., Pontarin G., Crocco L., Fabris S., Reichard P., and Bianchi V. Mitochondrial deoxynucleotide pools in quiescent fibroblasts: a possible model for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). J Biol Chem 280 26 (2005) 24472-24480
16. Pontarin G., Fijolek A., Pizzo P., Ferraro P., Rampazzo C., Pozzan T., et al. Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage. Proc Natl Acad Sci USA 105 46 (2008) 17801-17806
17. Nishigaki Y., Marti R., Copeland W.C., and Hirano M. Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J Clin Invest 111 12 (2003) 1913-1921
18. Lopez L.C., Akman H.O., Garcia-Cazorla A., Dorado B., Marti R., Nishino I., et al. Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase deficient mice. Hum Mol Genet (2008)
19. Spinazzola A., Marti R., Nishino I., Andreu A.L., Naini A., Tadesse S., et al. Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 277 6 (2002) 4128-4133
20. Saada A. Mitochondrial deoxyribonucleotide pools in deoxyguanosine kinase deficiency. Mol Genet Metab 95 3 (2008) 169-173
21. Jeppesen T.D., Schwartz M., Frederiksen A.L., Wibrand F., Olsen D.B., and Vissing J. Muscle phenotype and mutation load in 51 persons with the 3243A>G mitochondrial DNA mutation. Arch Neurol 63 12 (2006) 1701-1706
22. Zhou X., Solaroli N., Bjerke M., Stewart J.B., Rozell B., Johansson M., et al. Progressive loss of mitochondrial DNA in thymidine kinase 2-deficient mice. Hum Mol Genet 17 15 (2008) 2329-2335
23. Lara M.C., Weiss B., Illa I., Madoz P., Massuet L., Andreu A.L., et al. Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology 67 8 (2006) 1461-1463
24. Moran N.F., Bain M.D., Muqit M.M., and Bax B.E. Carrier erythrocyte entrapped thymidine phosphorylase therapy for MNGIE. Neurology 71 9 (2008) 686-688
25. Longley M.J., Clark S., Yu Wai Man C., Hudson G., Durham S.E., Taylor R.W., et al. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am J Hum Genet 78 6 (2006) 1026-1034
26. Wanrooij S., Goffart S., Pohjoismaki J.L., Yasukawa T., and Spelbrink J.N. Expression of catalytic mutants of the mtDNA helicase Twinkle and polymerase POLG causes distinct replication stalling phenotypes. Nucleic Acids Res 35 10 (2007) 3238-3251
27. Viscomi C., Spinazzola A., Maggioni M., Fernandez-Vizarra E., Massa V., Pagano C., et al. Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in Mpv17 knockout mice. Hum Mol Genet 18 1 (2009) 12-26
28. Hakonen A.H., Isohanni P., Paetau A., Herva R., Suomalainen A., and Lonnqvist T. Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 130 Pt. 11 (2007) 3032-3040
29. Taanman J.W., Rahman S., Pagnamenta A.T., Morris A.A., Bitner-Glindzicz M., Wolf N.I., et al. Analysis of mutant DNA polymerase gamma in patients with mitochondrial DNA depletion. Hum Mutat (2008)
30. Ashley N., O'Rourke A., Smith C., Adams S., Gowda V., Zeviani M., et al. Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations. Hum Mol Genet 17 (2008) 2496-2506
31. Dimmock D.P., Dunn J.K., Feigenbaum A., Rupar A., Horvath R., Freisinger P., et al. Abnormal neurological features predict poor survival and should preclude liver transplantation in patients with deoxyguanosine kinase deficiency. Liver Transpl 14 10 (2008) 1480-1485
32. Lara M.C., Valentino M.L., Torres-Torronteras J., Hirano M., and Marti R. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches. Biosci Rep 27 1-3 (2007) 151-163
33. Wenz T., Diaz F., Spiegelman B.M., and Moraes C.T. Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab 8 3 (2008) 249-256
34. Iacovino M., Granycome C., Sembongi H., Bokori-Brown M., Butow R.A., Holt I.J., et al. The conserved translocase Tim17 prevents mitochondrial DNA loss. Hum Mol Genet 18 1 (2009) 65-74
35. Moreno-Loshuertos R., Acin-Perez R., Fernandez-Silva P., Movilla N., Perez-Martos A., de Cordoba S.R., et al. Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat Genet 38 11 (2006) 1261-1268
36. Poulton J et al. Collated mutations in mitochondrial DNA depletion syndrome (excluding POLG1). Biochim Biophys Acta 2009.
37. Van Goethem G., Dermaut B., Lofgren A., Martin J.J., and Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28 3 (2001) 211-212
38. Spelbrink J., Li F., Tiranti V., Nikali K., Yuan Q., Tariq M., et al. Human mitochondrial DNA deletions associated with mutations in the gene for Twinkle, a Phage T7 Gene 4-Like protein localized to mitochondrial nucleoids. Nat Genet 28 (2001) 223-231
39. Kaukonen J, Juselius J, Tiranti V, Kyttala A, Zeviani M, Comi G, et al. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 2000;289:782-5.
40. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999;283:689-92.
41. Mandel H., Szargel R., Labay V., Elpeleg O., Saada A., Shalata A., et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 29 3 (2001) 337-341
42. Saada A., Shaag A., Mandel H., Nevo Y., Eriksson S., and Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 29 3 (2001) 342-344
43. Elpeleg O., Miller C., Hershkovitz E., Bitner-Glindzicz M., Bondi-Rubinstein G., Rahman S., et al. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet 76 6 (2005) 1081-1086
44. Ostergaard E., Christensen E., Kristensen E., Mogensen B., Duno M., Shoubridge E.A., et al. Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet 81 2 (2007) 383-387
45. Bourdon A., Minai L., Serre V., Jais J.P., Sarzi E., Aubert S., et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 39 6 (2007) 776-780
46. Hudson G, Amati-Bonneau P, Blakely EL, Stewart JD, He L, Schaefer AM, et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2007.
47. Amati-Bonneau P., Valentino M.L., Reynier P., Gallardo M.E., Bornstein B., Boissiere A., et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 131 Pt. 2 (2008) 338-351
48. Spinazzola A., Viscomi C., Fernandez-Vizarra E., Carrara F., D'Adamo P., Calvo S., et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 38 (2006) 570-575